Spead the news about Benitec, page-24

Daynos, I hear you mate. But consider this. The company has released myriad positive announcements on the ASX to very little effect in recent months. Can you imagine the disaster if positive efficacy results were released on the ASX, only for there to be precious little SP reaction?

While the dilution is a trade-off, I see it as good business sense, as efficacy will IMO result in a landslide of support once the company is NASDAQ listed.

I prefer a smaller piece of a much larger pie, so long as I'm eating pie for a long, long time to come...

-RS